A new study suggests that a single dose of psilocybin can lead to lasting anatomical changes in the brain, potentially explaining its therapeutic effects. Conducted at Baylor College of Medicine, this research involved 28 healthy volunteers who had never taken a psychedelic before. Participants received a 25mg dose of psilocybin to elicit a powerful psychedelic experience.
EEG results revealed a surge in brain entropy within an hour of taking psilocybin. Those with the largest spike in brain entropy reported better wellbeing a month later—indicating that these neural connections may indeed foster long-term mental health benefits.
Key findings:
- A single dose of psilocybin can induce anatomical changes in the brain.
- Changes in brain structure were still apparent a month after taking psilocybin.
- The study involved 28 healthy volunteers who had never taken a psychedelic before.
- Participants took a 25mg dose of psilocybin to elicit a powerful psychedelic experience.
- Those with the largest spike in brain entropy reported improved wellbeing one month later.
This study aligns with Texas’s increasing interest in psychedelic therapy. In recent years, Texas has passed legislation funding psychedelic research, particularly for veterans grappling with PTSD. Furthermore, the FDA is fast-tracking several psychedelic compounds for mental health conditions like treatment-resistant depression and major depressive disorder.
Prof. Robin Carhart-Harris remarked, “It’s remarkable to see potential anatomical brain changes one month after a single dose of any drug.” This underscores the urgency for further exploration into the therapeutic potentials of psychedelics.
Yet, uncertainties linger around safety and efficacy—especially concerning other compounds like ibogaine, which has known risks requiring trained medical oversight. As interest grows, it’s crucial to navigate these complexities carefully.
The stakes are high: over 49,000 Americans died by suicide in 2023 alone. With such alarming figures prompting renewed interest in innovative treatments, research into psychedelics could be pivotal. Logan Davidson noted, “Nothing we’re seeing play out on the national stage would have happened without Texas,” highlighting the state’s role as a catalyst for change in psychedelic policy and research.
